trending Market Intelligence /marketintelligence/en/news-insights/trending/1riar3z7c8deqkpk4xawuw2 content esgSubNav
In This List

Bayer, Monsanto deal nears closing with Indian regulator's approval

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bayer, Monsanto deal nears closing with Indian regulator's approval

The Competition Commission of India cleared Bayer AG's $62.5 billion acquisition of Monsanto Co., Reuters reported May 22.

The approval, reportedly among the deal's last antitrust clearance, is subject to compliance of certain modifications, the Indian regulator said in a tweet. Citing a source familiar with the matter, Reuters reported that the commission asked Bayer to divest its agriculture seeds, vegetable seeds, glufosinate-ammonium and digital agriculture business.

The deal recently received approval from South Africa's Competition Tribunal and required the sale of the entire global Liberty Link trait technology, Bayer's Liberty branded agrochemicals business as well as Bayer's South African cotton seed business.

Bayer has previously stated that it aims to close the deal in the second quarter.